Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 8Active not recruiting 7Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1

Interventions

pembrolizumab 26Cisplatin 14Nivolumab 11Cyclophosphamide 11Carboplatin 11Paclitaxel 9Docetaxel 9Radiotherapy, Intensity-Modulated 8Radiotherapy 8Magnetic Resonance Spectroscopy 8Radiosurgery 7Radiation 7Fluorouracil 7Bevacizumab 7Leucovorin 6Irinotecan 6Gemcitabine 6Doxorubicin 6venetoclax 5olaparib 5enzalutamide 5Prednisone 5Pemetrexed 5Oxaliplatin 5Metformin 5Azacitidine 5fludarabine 4atezolizumab 4Taxes 4Surveys and Questionnaires 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Filgrastim × 30 days × Clear all
NCT03434730 2026-05-26

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
46 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡